Description
HER2 (Trastuzumab Biosimilar) Human mAb was confirmed to bind to its intended target protein HER2 using flow cytometry. HER2 (Trastuzumab Biosimilar) Human mAb is produced at Cell Signaling Technology. Trastuzumab is an antibody directed against the extracellular region of human HER2.
Target
HER2/ErbB2
Target Alias Names
ERBB2, HER2
Isotype/Mimetic
IgG1 kappa
Animal-Derived Biomaterials Used
BSA
Sequence Available
Yes
Original Discovery Method
Immunization
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation